- Home
- ZYXI vs ECOR Comparison
ZYXI vs ECOR Comparison
Compare ZYXI & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZYXI
- ECOR
- Stock Information
- Founded
- ZYXI 1996
- ECOR 2005
- Country
- ZYXI United States
- ECOR United States
- Employees
- ZYXI N/A
- ECOR N/A
- Industry
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ZYXI Health Care
- ECOR Health Care
- Exchange
- ZYXI Nasdaq
- ECOR Nasdaq
- Market Cap
- ZYXI 44.8M
- ECOR 40.0M
- IPO Year
- ZYXI N/A
- ECOR 2018
- Fundamental
- Price
- ZYXI $1.17
- ECOR $4.95
- Analyst Decision
- ZYXI Hold
- ECOR Strong Buy
- Analyst Count
- ZYXI 3
- ECOR 2
- Target Price
- ZYXI $3.00
- ECOR $25.50
- AVG Volume (30 Days)
- ZYXI 78.1K
- ECOR 42.9K
- Earning Date
- ZYXI 10-30-2025
- ECOR 11-05-2025
- Dividend Yield
- ZYXI N/A
- ECOR N/A
- EPS Growth
- ZYXI N/A
- ECOR N/A
- EPS
- ZYXI N/A
- ECOR N/A
- Revenue
- ZYXI $144,808,000.00
- ECOR $27,700,000.00
- Revenue This Year
- ZYXI N/A
- ECOR $23.74
- Revenue Next Year
- ZYXI $7.07
- ECOR $42.02
- P/E Ratio
- ZYXI N/A
- ECOR N/A
- Revenue Growth
- ZYXI N/A
- ECOR 30.16
- 52 Week Low
- ZYXI $1.21
- ECOR $4.16
- 52 Week High
- ZYXI $9.33
- ECOR $19.49
- Technical
- Relative Strength Index (RSI)
- ZYXI 29.89
- ECOR 46.26
- Support Level
- ZYXI $1.30
- ECOR $4.88
- Resistance Level
- ZYXI $1.43
- ECOR $5.19
- Average True Range (ATR)
- ZYXI 0.07
- ECOR 0.22
- MACD
- ZYXI -0.01
- ECOR 0.00
- Stochastic Oscillator
- ZYXI 0.00
- ECOR 34.40
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.